Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds

NCT00189475 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Upper Respiratory Infection

Interventions

DRUG: Montelukast
DRUG: Placebo

Sponsor

Deborah Gentile

Collaborators

[object Object]